220 related articles for article (PubMed ID: 37456825)
1. Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer.
Wang G; Tan Y; Jiang Y; Liu J; Su Y; Sun Z; Liu B
Risk Manag Healthc Policy; 2023; 16():1259-1271. PubMed ID: 37456825
[TBL] [Abstract][Full Text] [Related]
2. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
Li Y; Bai M; Gao Y
World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
4. Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: A population-based study.
Yang Y; He C
Front Surg; 2022; 9():1066092. PubMed ID: 36743892
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
6. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9.
Li Y; Zhang X
Front Surg; 2022; 9():916483. PubMed ID: 36090344
[TBL] [Abstract][Full Text] [Related]
8. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
[TBL] [Abstract][Full Text] [Related]
9. Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study.
Deng ZJ; Lu J; Nie RC; Fang JM; Chen XJ; Liu JJ; Li XZ; Chen YB; Huang CM; Lian L; Peng JS; Chen S
Ann Surg Oncol; 2022 Dec; 29(13):8214-8224. PubMed ID: 35798893
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
11. A Modified ypTNM Staging System-Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy.
Li Z; Xiao Q; Wang Y; Wang W; Li S; Shan F; Zhou Z; Ji J
Cancer Manag Res; 2020; 12():2047-2055. PubMed ID: 32256112
[TBL] [Abstract][Full Text] [Related]
12. Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.
Wang F; Fan L; Zhao Q; Liu Y; Zhang Z; Wang D; Zhao X; Li Y; Tan B
Medicine (Baltimore); 2022 Sep; 101(35):e30141. PubMed ID: 36107576
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
Front Oncol; 2021; 11():784156. PubMed ID: 34869040
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a nomogram predicting overall survival for Gastric adenocarcinoma patients with radical gastrectomy.
He Z; Lin F; Cheng T; Gao J; Wang H; Zhang Z; Deng X
Scand J Gastroenterol; 2024; 59(1):52-61. PubMed ID: 37632275
[TBL] [Abstract][Full Text] [Related]
15. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
[TBL] [Abstract][Full Text] [Related]
16. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study.
Sun Y; Li Z; Tian Y; Gao C; Liang B; Cao S; Liu X; Liu X; Meng C; Xu J; Yang H; Zhou Y
BMC Gastroenterol; 2023 Apr; 23(1):117. PubMed ID: 37041468
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
[TBL] [Abstract][Full Text] [Related]
20. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]